Kong Yi, Huo Jian-li, Xu Wen, Xiong Jin, Li Yun-man, Wu Wu-tong
Department of Bio-pharmaceutics, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.
Toxicon. 2009 Aug;54(2):103-9. doi: 10.1016/j.toxicon.2009.03.027. Epub 2009 Apr 5.
AAP, a tripeptide that inhibited rabbit platelet aggregation, was isolated from Agkistrodon acutus venom by ion-exchange, gel filtration and reverse-phase chromatography. Amino acid sequences which determined mainly by amino acid analyses and NMR spectroscopy indicated it was a tripeptide including pyroglutamic acid, asparagine and tryptophane residues. The ESMS experiment assigned a molecular weight of 429 Da. AAP inhibited rabbit platelet aggregation induced by ADP, PAF-acether, collagen and thrombin, the IC(50)s were 178 microM, 332 microM, 179 microM and 203 microM, respectively. AAP also inhibited thrombus formation in vivo thrombosis model and prevented the combination between fibrinogen and GP IIb/IIIa. Besides, AAP was not toxic after intravenous injection into mice at a higher dose. Those studies might be helpful to delineate unknown mechanisms involved in platelet aggregation and serve as a model for developing antithrombotic agents.
从尖吻蝮蛇毒中通过离子交换、凝胶过滤和反相色谱法分离出一种抑制兔血小板聚集的三肽——AAP。主要通过氨基酸分析和核磁共振光谱确定的氨基酸序列表明它是一种包含焦谷氨酸、天冬酰胺和色氨酸残基的三肽。电喷雾质谱实验测得其分子量为429道尔顿。AAP抑制由ADP、血小板活化因子、胶原和凝血酶诱导的兔血小板聚集,其半数抑制浓度(IC50)分别为178微摩尔/升、332微摩尔/升、179微摩尔/升和203微摩尔/升。AAP还能抑制体内血栓形成模型中的血栓形成,并阻止纤维蛋白原与糖蛋白IIb/IIIa的结合。此外,高剂量静脉注射AAP对小鼠无毒。这些研究可能有助于阐明血小板聚集中未知的机制,并为开发抗血栓药物提供模型。